Delivery Order SPE2DX15D8002-SPE2DX24F2TM2
Award Date 10/26/23
Potential Completion Date 10/27/23
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Minot, ND, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $12,922.26, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract is a firm-fixed-price delivery order with a period of performance through November 13, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, with a focus on serving the Department of...
- This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $5,560.45 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,674.18 and a performance period ending on January 4, 2023. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001 and valued at $999,999,999.00, as part of the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,871.26, is for the delivery of Eliquis 5 mg tablets. It is not a set-aside contract. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a significant single-award Indefinite Delivery Contract...
- This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $11,102.42 firm fixed-price delivery order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a performance period ending on July 6, 2022. The contract is not set-aside and is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $14,529.07 firm fixed-price contract is for the delivery of Eliquis 5 mg tablets to support U.S. military medical operations. The contract is not set-aside and has an ultimate completion date of April 27, 2023. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, with a ceiling value of $7,840.14, is for the delivery of 4562392114 - 60-count tablets of Eliquis 5 mg. The contract has an ultimate completion date of October 5, 2023. Dakota Drug, Inc. is a key supplier for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support...
- This is a $5,024.65 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The award has an ultimate completion date of October 23, 2024 and is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) for a comprehensive range of pharmaceutical products,...
- This is a $8,471.66 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has an ultimate completion date of January 24, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablet medication. The contract has a fixed price of $2,732.22 and a performance period extending until January 11, 2024. The contract is not set aside and is a delivery order under Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This...